Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON34678
NL-OMON34678
Recruiting
N/A

The significance of biomarkers in the blood in the diagnosis and the course of Alzheimer*s disease - Blood biomarkers for Alzheimer*s disease

niversitair Medisch Centrum Sint Radboud0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAlzheimers disease10012272

Overview

Phase
N/A
Intervention
Not specified
Conditions
Alzheimers disease
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
100
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •Patient inclusion criteria:
  • •\- Patients with Alzheimer's disease
  • •\- Mentally competent AD patient \[Clinical Dementia Rating (CDR) scale 1]
  • •\- The diagnosis of probable Alzheimer's disease\* should be made according to the NINCDS\-
  • •ADRDA criteria.
  • •\- Patients or carers should agree with the study (written informed consent is required form
  • •patients or their carers).;Inclusion criteria control group (healthy subjects in group A):
  • •\- Men or women without cognitive or psychiatric disorders
  • •\- Mini\-Mental State Examination (MMSE) score \>\= 28

Exclusion Criteria

  • •Patient exclusion criteria:
  • •\- Mentally incompetent AD patient \[Clinical Dementia Rating (CDR) scale 2 and 3]
  • •\- Patients with infection or inflammatory disease less than 1 months ago.
  • •\- Patients with active malignancy.
  • •\- Patients with autoimmune disease (e.g. temporal arteritis, polymyalgia rheumatica).
  • •\- Patients who use immune modulating drugs (e.g. Immunocyanin, interferon gamma, immunoglobulin).
  • •\- Patients with renal dysfunction (MDRD \<50\)
  • •\- Patients with liver impairment
  • •\- Patients with decreased serum albumin \<25 g / l;Exclusion criteria control group:
  • •\- Conform the patient exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Analysis of biomarkers in the peripheral blood of patients with soft tissue sarcomaC49.9C41.9Connective and soft tissue, unspecifiedBone and articular cartilage, unspecified
DRKS00009587niversitätsklinikum Freiburg300
Recruiting
N/A
Explorative study of emerging blood biomarkers in progressive multiple sclerosisG35Multiple sclerosis
DRKS00020132Reha- und Universitätsklinikum Ulm240
Recruiting
N/A
Identification of Blood Biomarkers Associated with Cardiac Remodeling after Myocardial Infarctio
JPRN-UMIN000045598Graduate School of Medicine and Faculty of Medicine, The University of Tokyo200
Completed
N/A
Elucidating the relationship between blood biomarker levels and deterioration in Health Status -The prospective cohort study of Kagome employeesMedicine in general
JPRN-UMIN000050889KAGOME Co., LTD160
Active, Not Recruiting
N/A
Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitis
JPRN-jRCT1050210175Tamagawa-Mineoka Risa15